[go: up one dir, main page]

NZ516564A - Cancer therapy - Google Patents

Cancer therapy

Info

Publication number
NZ516564A
NZ516564A NZ516564A NZ51656400A NZ516564A NZ 516564 A NZ516564 A NZ 516564A NZ 516564 A NZ516564 A NZ 516564A NZ 51656400 A NZ51656400 A NZ 51656400A NZ 516564 A NZ516564 A NZ 516564A
Authority
NZ
New Zealand
Prior art keywords
cancer therapy
medicament
agent
eradicating
retarding
Prior art date
Application number
NZ516564A
Inventor
Geoffrey Wayne Krissansen
Jagat Rakesh Kanwar
Lai-Ming Hing
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Priority to NZ516564A priority Critical patent/NZ516564A/en
Priority claimed from PCT/NZ2000/000098 external-priority patent/WO2000076497A1/en
Publication of NZ516564A publication Critical patent/NZ516564A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A use of a immunotherapeutic agent and a tumour growth- restricting agent in the preparation of a medicament for retarding or eradicating an advanced or large tumour burden wherein said medicament is formulated for simultaneous, separate or sequential administration of the agents.
NZ516564A 1999-06-14 2000-06-14 Cancer therapy NZ516564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ33625999 1999-06-14
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy
PCT/NZ2000/000098 WO2000076497A1 (en) 1999-06-14 2000-06-14 Cancer therapy

Publications (1)

Publication Number Publication Date
NZ516564A true NZ516564A (en) 2003-10-31

Family

ID=29253761

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ516564A NZ516564A (en) 1999-06-14 2000-06-14 Cancer therapy

Country Status (1)

Country Link
NZ (1) NZ516564A (en)

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MXPA03010121A (en) Combination therapy using anti-egfr antibodies and anti-hormonal agents.
IL155781A0 (en) Effective antitumor treatments
MY164077A (en) Compositions and uses of et743 for treating cancer
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
GB0013674D0 (en) Therapeutic use
HK1043313A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
GEP20063773B (en) Steroid Sulphatase Inhibitors
AU7031500A (en) Therapeutic quinazoline compounds
IL182352A0 (en) The use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
NZ504938A (en) Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
HK1040204A1 (en) Synergistic tumorcidal response induced by histamine
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
NZ511150A (en) Non-fermented osmotic laxative for treating and preventing colorectal cancers
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
MXPA04001912A (en) Novel aminobenzoephenones.
ZA877901B (en) Active compounds for use in the treatment of tumors
AU2001236529A1 (en) Combination therapy for cancer
NZ516564A (en) Cancer therapy
YU29803A (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
MXPA05009849A (en) Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor.
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: CANCER RESEARCH TECHNOLOGY LIMITED, GB

Free format text: OLD OWNER(S): CANCER RESEARCH VENTURES LIMITED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed